Información del producto
- HMS 5552
Dorzagliatin is a new drug for the treatment of type 2 diabetes. It has been shown to be effective in diabetic patients, with a long-term efficacy and pharmacokinetic properties. Dorzagliatin has also been shown to have a pharmacological effect on β-cells, which are cells that produce insulin in the pancreas. This drug's activity is due to its ability to inhibit the production of growth factors and plasma concentration-time curve. In addition, dorzagliatin does not have any enantiomeric isomers and can be detected in blood plasma within one hour after administration.
Propiedades químicas
Consulta técnica sobre: 3D-BD167920 Dorzagliatin
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.